Cargando…

Supervised injection facilities in Canada: past, present, and future

Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Thomas, Mitra, Sanjana, Kennedy, Mary Clare, McNeil, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437687/
https://www.ncbi.nlm.nih.gov/pubmed/28521829
http://dx.doi.org/10.1186/s12954-017-0154-1
_version_ 1783237641411493888
author Kerr, Thomas
Mitra, Sanjana
Kennedy, Mary Clare
McNeil, Ryan
author_facet Kerr, Thomas
Mitra, Sanjana
Kennedy, Mary Clare
McNeil, Ryan
author_sort Kerr, Thomas
collection PubMed
description Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and closed, Canada’s first sanctioned SIF opened in 2003. However, while a large body of evidence highlights the successes of this SIF in reducing the health and social harms associated with injection drug use, extraordinary efforts were needed to preserve it, and continued activism by local people who inject drugs (PWID) and healthcare providers was needed to promote further innovation and address gaps in SIF service delivery. A growing acceptance of SIFs and increasing concern about overdose have since prompted a rapid escalation in efforts to establish SIFs in cities across Canada. While much progress has been made in that regard, there is a pressing need to create a more enabling environment for SIFs through amendment of federal legislation. Further innovation in SIF programming should also be encouraged through the creation of SIFs that accommodate assisted injecting, the inhalation of drugs. As well, peer-run, mobile, and hospital-based SIFs also constitute next steps needed to optimize the impact of this form of harm reduction intervention.
format Online
Article
Text
id pubmed-5437687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54376872017-05-22 Supervised injection facilities in Canada: past, present, and future Kerr, Thomas Mitra, Sanjana Kennedy, Mary Clare McNeil, Ryan Harm Reduct J Review Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of supervised injection facilities (SIFs), and after several unsanctioned SIFs operated briefly and closed, Canada’s first sanctioned SIF opened in 2003. However, while a large body of evidence highlights the successes of this SIF in reducing the health and social harms associated with injection drug use, extraordinary efforts were needed to preserve it, and continued activism by local people who inject drugs (PWID) and healthcare providers was needed to promote further innovation and address gaps in SIF service delivery. A growing acceptance of SIFs and increasing concern about overdose have since prompted a rapid escalation in efforts to establish SIFs in cities across Canada. While much progress has been made in that regard, there is a pressing need to create a more enabling environment for SIFs through amendment of federal legislation. Further innovation in SIF programming should also be encouraged through the creation of SIFs that accommodate assisted injecting, the inhalation of drugs. As well, peer-run, mobile, and hospital-based SIFs also constitute next steps needed to optimize the impact of this form of harm reduction intervention. BioMed Central 2017-05-18 /pmc/articles/PMC5437687/ /pubmed/28521829 http://dx.doi.org/10.1186/s12954-017-0154-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Kerr, Thomas
Mitra, Sanjana
Kennedy, Mary Clare
McNeil, Ryan
Supervised injection facilities in Canada: past, present, and future
title Supervised injection facilities in Canada: past, present, and future
title_full Supervised injection facilities in Canada: past, present, and future
title_fullStr Supervised injection facilities in Canada: past, present, and future
title_full_unstemmed Supervised injection facilities in Canada: past, present, and future
title_short Supervised injection facilities in Canada: past, present, and future
title_sort supervised injection facilities in canada: past, present, and future
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437687/
https://www.ncbi.nlm.nih.gov/pubmed/28521829
http://dx.doi.org/10.1186/s12954-017-0154-1
work_keys_str_mv AT kerrthomas supervisedinjectionfacilitiesincanadapastpresentandfuture
AT mitrasanjana supervisedinjectionfacilitiesincanadapastpresentandfuture
AT kennedymaryclare supervisedinjectionfacilitiesincanadapastpresentandfuture
AT mcneilryan supervisedinjectionfacilitiesincanadapastpresentandfuture